
4 Midcap Promoter Holding Between 25 and 50 Per Cent Stocks to Watch for Future Multibagger Potential: Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart
Lupin Rs 1,959.90. Fortis Healthcare Rs 734.70. Sundaram Finance Rs 3,902.10. Vishal Mega Mart Rs 88.70. Market caps from Rs 41,598 crore to Rs 91,359 crore. Data as of 26 Oct 2026.
Updated: 27 Oct 2026 • 4:22 pm
Posted by:

Quick Answer
Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart are the 4 picks in this promoter holding between 25 and 50 per cent stocks watchlist, with market caps between Rs 41,598 crore and Rs 91,359 crore. Lupin stands out for the highest return on equity at 23.76%, while Fortis Healthcare offers the biggest five-year price gain at 241.47%. PE ratios run from 16.46 to 52.24, so compare each one with its industry PE before investing. All figures are as of 26 October 2026.
Promoter holding between 25 and 50 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart meet that test, with market caps from Rs 41,598 crore to Rs 91,359 crore and Lupin offering the highest return on equity at 23.76%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and promoter holding between 25 and 50 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and promoter holding between 25 and 50 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening promoter holding between 25 and 50 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 26 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Promoter Holding Between 25 and 50 Per Cent Stocks and Why Do They Attract Multibagger Interest?
Promoter holding between 25 and 50 per cent stocks are shares of mid sized companies where promoters hold between a quarter and a half of the equity, a balance of founder commitment and wide public and institutional ownership. The four here cover pharmaceuticals, hospitals, financial services and value retail.
This ownership mix keeps promoters invested in the outcome while giving institutions and the public a large say in how the company is run. Within promoter holding between 25 and 50 per cent stocks, the four companies show rising profit. For promoter holding between 25 and 50 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read promoter holding between 25 and 50 per cent stocks, the common thread is rising profit backed by complete financial data. Investors researching promoter holding between 25 and 50 per cent stocks get a fuller picture by reading growth and valuation together. The table below lines up promoter holding between 25 and 50 per cent stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use promoter holding between 25 and 50 per cent stocks as a starting point for your own research.
Promoter Holding Between 25 and 50 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 26 October 2026. Lupin combines the lowest PE of the group, 16.46, with the highest return on equity, 23.76%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Lupin | 1,959.90 | 91,359 | 16.46 | 36.42 | 23.76% | 4.07 | 1,900.00 to 2,529.50 |
| Fortis Healthcare | 734.70 | 55,926 | 52.24 | 60.75 | 10.53% | 5.66 | 565.00 to 757.40 |
| Sundaram Finance | 3,902.10 | 44,512 | 20.05 | 17.70 | 13.82% | 2.99 | 3,902.10 to 5,642.00 |
| Vishal Mega Mart | 88.70 | 41,598 | 46.73 | 64.73 | 11.32% | 5.60 | 87.35 to 149.82 |
Lupin: Revenue Up 26.76% in FY26
Lupin is a global pharmaceutical company with a large presence in the United States, India and other markets across generics, branded drugs and respiratory products. It reported FY26 revenue of Rs 29,038.95 crore, up 26.76% year on year, and net profit of Rs 5,355.47 crore, up 61.98%. Revenue has compounded at 14.98% a year since FY22. Operating margin was 31.06% in FY26. The debt-to-equity ratio is 0.29.
In the June 2026 quarter, revenue rose 32.45% to Rs 8,407.21 crore and net profit grew 16.01% to Rs 1,416.98 crore. The share price has gained 111.00% over five years. Foreign investors raised their holding from 21.25% in June 2025 to 22.42% in June 2026. The stock trades at a PE of 16.46 against an industry PE of 36.42, below the sector average, with a return on equity of 23.76%.
Fortis Healthcare: Five-Year Gain of 241.47%
Fortis Healthcare operates a chain of hospitals and diagnostic centres across India. It reported FY26 revenue of Rs 9,178.50 crore, up 16.93% year on year, and net profit of Rs 1,064.19 crore, up 31.48%. Net profit has compounded at 7.73% a year since FY22, while revenue has grown 12.43% a year. Operating margin was 22.41% in FY26. The debt-to-equity ratio is 0.35.
The stock trades at a PE of 52.24 against an industry PE of 60.75, below the sector average. In the June 2026 quarter, revenue rose 17.29% to Rs 2,559.50 crore and net profit grew 2.26% to Rs 272.80 crore. The share price has gained 241.47% over five years. Domestic institutions raised their holding from 29.79% in June 2025 to 32.23% in June 2026.
Sundaram Finance: Quarterly Profit Up 38.14%
Sundaram Finance is one of India's oldest non-banking finance companies, with a strong record in commercial vehicle and car loans. It reported FY26 revenue of Rs 9,873.12 crore, up 15.30% year on year, and net profit of Rs 2,005.40 crore, up 10.62%. Net profit has compounded at 17.10% a year since FY22, while revenue has grown 17.69% a year. Operating margin was 77.70% in FY26.
In the June 2026 quarter, revenue rose 12.76% to Rs 2,653.34 crore and net profit grew 38.14% to Rs 568.86 crore. The share price has gained 68.83% over five years. Domestic institutions raised their holding from 7.22% in June 2025 to 8.00% in June 2026. The stock trades at a PE of 20.05 against an industry PE of 17.70, with a return on equity of 13.82%.
Vishal Mega Mart: 42.63% Profit CAGR Since FY22
Vishal Mega Mart runs value retail stores selling apparel, general merchandise and FMCG products across India. It reported FY26 revenue of Rs 12,992.61 crore, up 20.58% year on year, and net profit of Rs 839.23 crore, up 32.80%. Net profit has compounded at 42.63% a year since FY22, while revenue has grown 23.12% a year. Operating margin was 15.51% in FY26. The debt-to-equity ratio is 0.27.
The stock trades at a PE of 46.73 against an industry PE of 64.73, below the sector average. In the June 2026 quarter, revenue rose 19.09% to Rs 3,760.15 crore and net profit grew 25.57% to Rs 258.77 crore. Domestic institutions raised their holding from 25.42% in September 2025 to 36.45% in September 2026.
Promoter Holding Between 25 and 50 Per Cent Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these promoter holding between 25 and 50 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Lupin | 29,038.95 | 5,355.47 | 26.76% | 14.98% | 32.45% | 31.40% |
| Fortis Healthcare | 9,178.50 | 1,064.19 | 16.93% | 12.43% | 17.29% | 22.22% |
| Sundaram Finance | 9,873.12 | 2,005.40 | 15.30% | 17.69% | 12.76% | 78.41% |
| Vishal Mega Mart | 12,992.61 | 839.23 | 20.58% | 23.12% | 19.09% | 15.50% |
Check the Univest Screener for live data on these promoter holding between 25 and 50 per cent stocks
Institutional Holding in Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart
Institutional holding shows who is backing these promoter holding between 25 and 50 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Fortis Healthcare has the deepest institutional backing, with FII and DII together holding 57.43% as of June 2026. Domestic institutions increased their holding over the past year in Fortis Healthcare (from 29.79% to 32.23%), Sundaram Finance (from 7.22% to 8.00%) and Vishal Mega Mart (from 25.42% to 36.45%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Lupin | 46.85% | 22.42% | 24.65% | 6.08% | June 2026 |
| Fortis Healthcare | 31.17% | 25.20% | 32.23% | 11.40% | June 2026 |
| Sundaram Finance | 37.21% | 18.58% | 8.00% | 36.21% | June 2026 |
| Vishal Mega Mart | 40.02% | 18.75% | 36.45% | 4.77% | September 2026 |
Risks to Weigh in Promoter Holding Between 25 and 50 Per Cent Stocks
Being careful with promoter holding between 25 and 50 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Sundaram Finance trades at a PE of 20.05 against an industry PE of 17.70, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Promoter Holding Between 25 and 50 Per Cent Stocks
Picking from promoter holding between 25 and 50 per cent stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (17.70 to 64.73) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart live prices.
Conclusion
Among promoter holding between 25 and 50 per cent stocks, Lupin stands out for the highest return on equity at 23.76%, Fortis Healthcare for the biggest five-year price gain at 241.47%, Sundaram Finance for the strongest latest-quarter profit growth at 38.14% and Vishal Mega Mart for the fastest profit growth, 42.63% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing promoter holding between 25 and 50 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Promoter Holding Between 25 and 50 Per Cent Stocks to Watch
Which are the best promoter holding between 25 and 50 per cent stocks to watch for multibagger potential?
Ans. Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart are the 4 names this list highlights, with market caps of Rs 91,359 crore, Rs 55,926 crore, Rs 44,512 crore and Rs 41,598 crore respectively. Lupin is notable for the highest return on equity at 23.76%. Fortis Healthcare stands out for the biggest five-year price gain at 241.47%. Sundaram Finance offers the strongest latest-quarter profit growth at 38.14%. Vishal Mega Mart brings the fastest profit growth, 42.63% a year since FY22. These are watchlist names for promoter holding between 25 and 50 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Lupin a good stock for long-term investors?
Ans. Lupin has a return on equity of 23.76%, a PE of 16.46 against an industry PE of 36.42 and a market cap of Rs 91,359 crore. FY26 revenue rose 26.76%, and June 2026 quarter net profit grew 16.01%. Long-term returns in promoter holding between 25 and 50 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Vishal Mega Mart become a multibagger from here?
Ans. Vishal Mega Mart has a market cap of Rs 41,598 crore. A multibagger outcome in promoter holding between 25 and 50 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 42.63% a year since FY22, and FY26 revenue rose 20.58%. At a PE of 46.73 against an industry PE of 64.73, valuation should be checked against that growth before investing.
What is the market cap of Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart?
Ans. As of 26 October 2026, Lupin has a market cap of Rs 91,359 crore, Fortis Healthcare has a market cap of Rs 55,926 crore, Sundaram Finance has a market cap of Rs 44,512 crore and Vishal Mega Mart has a market cap of Rs 41,598 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on promoter holding between 25 and 50 per cent stocks.
What are the risks of investing in promoter holding between 25 and 50 per cent stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Sundaram Finance trades at a PE of 20.05 against an industry PE of 17.70, so earnings growth needs to hold up.
Is Lupin trading below its industry PE?
Ans. Lupin trades at a PE of 16.46 against an industry PE of 36.42. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (FY26 revenue rose 26.76% and June 2026 quarter net profit grew 16.01%) and balance sheet strength before drawing a conclusion.
How much do institutions hold in Lupin, Fortis Healthcare, Sundaram Finance and Vishal Mega Mart?
Ans. As of the latest reported quarter, FII and DII together hold 47.07% of Lupin (22.42% and 24.65%), 57.43% of Fortis Healthcare (25.20% and 32.23%), 26.58% of Sundaram Finance (18.58% and 8.00%) and 55.20% of Vishal Mega Mart (18.75% and 36.45%). Rising institutional holding is a useful signal in promoter holding between 25 and 50 per cent stocks, though it should be read with earnings trends rather than on its own.
Recent Articles

3 Pumps and Valves Specialist, Water Treatment Solutions Provider and Wear-Resistant Castings Producer Stocks With a Strong Future Roadmap: Kirloskar Brothers, Ion Exchange (India) and AIA Engineering
27 October 2026

3 Largest Private Healthcare Group, Affordable Cardiac Care Hospital Group and Ingredients and Formulations Maker Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Narayana Hrudayalaya and Granules India
27 October 2026

3 Electronics Manufacturing Services Company, Defence Shipyard and Oil and Gas Engineering Consultant Stocks With a Strong Future Roadmap: Syrma SGS Technology, Mazagon Dock Shipbuilders and Engineers India
27 October 2026

3 Hospital Network Operator, Respiratory Medicines Leader and Infusion and Catheter Devices Maker Stocks With a Strong Future Roadmap: Fortis Healthcare, Cipla and Poly Medicure
27 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Pumps and Valves Specialist, Water Treatment Solutions Provider and Wear-Resistant Castings Producer Stocks With a Strong Future Roadmap: Kirloskar Brothers, Ion Exchange (India) and AIA Engineering
3 Largest Private Healthcare Group, Affordable Cardiac Care Hospital Group and Ingredients and Formulations Maker Stocks With a Strong Future Roadmap: Apollo Hospitals Enterprise, Narayana Hrudayalaya and Granules India
3 Electronics Manufacturing Services Company, Defence Shipyard and Oil and Gas Engineering Consultant Stocks With a Strong Future Roadmap: Syrma SGS Technology, Mazagon Dock Shipbuilders and Engineers India
3 Hospital Network Operator, Respiratory Medicines Leader and Infusion and Catheter Devices Maker Stocks With a Strong Future Roadmap: Fortis Healthcare, Cipla and Poly Medicure
3 US Generics and Branded Medicines Company, Global Generics Maker and Chronic Therapy Brands Company Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Dr. Reddy's Laboratories and Eris Lifesciences

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





